HIGHLIGHTS
- who: Bombesin Receptors as a et al. from the Institute of Mental Health Research and Departments of Psychiatry and Cellular and Molecular Medicine, School of Psychology, University of Ottawa have published the research: Bombesin Receptors as a Novel Anti-Anxiety Therapeutic Target: BB Receptor Actions on Anxiety through Alterations of Serotonin Activity, in the Journal: (JOURNAL) of October/11,/2006
- how: Given the potential role of 5-HT in anxiety the authors examined the effects of 5-HT lesions (using 57DHT) on BB1/BB2 receptor binding at the DRN and determined whether PD 176252 administered . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.